These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6761868)

  • 21. [Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
    Kokron O
    Osterr Z Onkol; 1974; (5-6):123-7. PubMed ID: 4377798
    [No Abstract]   [Full Text] [Related]  

  • 22. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
    [No Abstract]   [Full Text] [Related]  

  • 23. New drug found active against lung cancers.
    Hospitals; 1982 Jun; 56(12):38. PubMed ID: 7042515
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma.
    Corsi A; Calabresi F; Greco C
    Br J Cancer; 1978 Nov; 38(5):631-3. PubMed ID: 728352
    [No Abstract]   [Full Text] [Related]  

  • 25. Ifosfamide as single-agent chemotherapy in inoperable non-small-cell lung cancer.
    Peake MD; Parker D
    Lancet; 1985 Aug; 2(8453):496-7. PubMed ID: 2863510
    [No Abstract]   [Full Text] [Related]  

  • 26. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
    Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Saiers JH; Slavik M
    Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.
    Carter SK
    J Natl Cancer Inst; 1976 Aug; 57(2):235-44. PubMed ID: 794496
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in the chemotherapy of malignant tumors].
    Cavalli F
    Ther Umsch; 1985 Aug; 42(8):541-6. PubMed ID: 3863258
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ifosfamide in the treatment of solid tumors and their metastases].
    Wicart L
    Nouv Presse Med; 1976 Apr; 5(15):996-8. PubMed ID: 778786
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical adjuvant chemotherapy for carcinomas.
    Bonadonna G
    Antibiot Chemother (1971); 1978; 24():83-94. PubMed ID: 566078
    [No Abstract]   [Full Text] [Related]  

  • 33. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
    McNiel NO; Morgan LR
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies of ifosfamide for gynecological malignancies].
    Kohno I; Kazuta M; Miyao J; Kunimi N; Kawamoto M; Tanimura T; Fujiwara K; Sekiba K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1278-84. PubMed ID: 6870299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
    Burkert H; Schnitker J; Fichtner E
    MMW Munch Med Wochenschr; 1979 Jun; 121(22):760-2. PubMed ID: 112422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
    Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
    Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():1-192. PubMed ID: 6414687
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cisplatin].
    Ogawa M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1140-6. PubMed ID: 6326687
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of cancer chemotherapy in primary ovarian cancer in rats--observation of histological effect by light and electron microscopy].
    Nishida T; Nishida T; Oda T; Sugiyama T; Iwanaga S; Katabuchi H; Araki T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):8-12. PubMed ID: 6421965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.